loader
Please Wait
Applying Filters...

Promoted Content Promoted Content

X

What is Route Evaluation & Development? A CDMO that can optimize your API synthesis process early during technology transfer will reduce the risk of project delay or failure. That will also help your molecule run more efficiently in their plant. And time is money. Most medicinal chemists design novel active pharmaceutical ingredients (APIs) to secure a patent and IP protection, not to create a scalable production process. That makes sense. They are racing against the clock, running through fail

proveris-scientific-Default-Wallpaper
proveris-scientific-Default-Wallpaper
Filters Filter
×
FILTER DATA :

filter

Aesica Pharmaceuticals Limited

Bellen Chemistry

Bioindustria L.I.M. Spa

Biolink LifeSciences

CARBOGEN AMCIS AG

CLEARSYNTH LABS LIMITED

Cambrex Corporation

Cayman Chemical Company Inc

ChemCon GmbH

Eurofins CDMO

Evotec

Laboratorium Ofichem B.V

M2i Group

Minakem

Nanjing Dorra Pharmaceutical Technology Co.,Ltd

PMC Isochem

POLYPHARMA TECH & SCIENCES

SANOFI Active Ingredient Solutions

Siegfried AG

UQUIFA

ZCL Chemicals Limited

filter

CHINA

FRANCE

GERMANY

INDIA

ITALY

NETHERLANDS

SPAIN

SWITZERLAND

UNITED KINGDOM

UNITED STATES

Close
4